Related Experiment Video
Updated: Mar 1, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.2K
Predisposing factors for atrial fibrillation in the elderly
Kristina Wasmer1, Lars Eckardt1, Günter Breithardt1
1Division of Electrophysiology, Department of Cardiovascular Medicine, University Hospital Münster, Germany.
Journal of Geriatric Cardiology : JGC
|June 9, 2017
Summary
Atrial fibrillation (AF) in older adults stems from cardiovascular aging and increased comorbidities. Age-related cellular changes and prolonged exposure to risk factors contribute to AF development in the elderly.
Area of Science:
- Cardiology
- Gerontology
- Electrophysiology
Background:
- Atrial fibrillation (AF) prevalence increases with age.
- Cardiovascular aging and comorbidities are key factors in elderly AF.
- Existing risk factors contribute to AF across age groups.
Purpose of the Study:
- To explore the relationship between aging, cardiovascular disease, and atrial fibrillation in the elderly.
- To identify age-specific mechanisms predisposing elderly individuals to AF.
Main Methods:
- Review of existing literature on cardiovascular aging and AF.
- Analysis of epidemiological data on AF prevalence in elderly populations.
- Examination of cellular and structural changes associated with aging and AF.
Main Results:
- Cardiovascular aging and increased comorbidities are primary drivers of AF in the elderly.
- Prolonged exposure to risk factors leads to structural heart changes promoting AF.
- Age-related alterations in cellular electrophysiology and structure contribute to AF susceptibility.
Conclusions:
- Age-related cardiovascular changes and comorbidities significantly increase AF risk in the elderly.
- Both cumulative risk factor exposure and intrinsic aging processes underlie AF in older adults.
- Further research into age-related cellular mechanisms is needed to understand and prevent elderly AF.
More Related Videos
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
285
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
01:15Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
302
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
302
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
288
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
288
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
709
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
709
01:24Drug Toxicity: Risk factors
60
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
60